English
简体中文
Total: £ 56.28
Published Date: 2022-06-23 | Pages: 117 | Tables: 163 | Pharma & Healthcare
Cytokines are a broad and loose category of small proteins (~5–20 kDa) that are important in cell signaling. Cytokines are peptides, and cannot cross the lipid bilayer of cells to enter the cytoplasm. Cytokines have been shown to be involved in autocrine signaling, paracrine signaling and endocrine signaling as immunomodulating agents. Their definite distinction from hormones is still part of ongoing research. Cytokines include chemokines, interferons, interleukins, lymphokines, and tumour necrosis factors, but generally not hormones or growth factors (despite some overlap in the terminology). Cytokines are produced by a broad range of cells, including immune cells like macrophages, B lymphocytes, T lymphocytes and mast cells, as well as endothelial cells, fibroblasts, and various stromal cells; a given cytokine may be produced by more than one type of cell. Some cytokines have been developed into protein therapeutics using recombinant DNA technology. Recombinant cytokines being used as drugs as of 2014 include: Bone morphogenetic protein (BMP), used to treat bone-related conditions Erythropoietin (EPO), used to treat anemia Granulocyte colony-stimulating factor (G-CSF), used to treat neutropenia in cancer patients Granulocyte macrophage colony-stimulating factor (GM-CSF), used to treat neutropenia and fungal infections in cancer patients Interferon alfa, used to treat hepatitis C and multiple sclerosis Interferon beta, used to treat multiple sclerosis Interleukin 2 (IL-2), used to treat cancer. Interleukin 11 (IL-11), used to treat thrombocytopenia in cancer patients. Interferon gamma is used to treat chronic granulomatous disease and osteopetrosis
Due to the COVID-19 pandemic, the global Recombinant Cytokines Drug market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Recombinant Cytokines Drug market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Recombinant Cytokines Drug landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Interferon accounting for % of the Recombinant Cytokines Drug global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hepatitis B segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of Recombinant Cytokines Drug include Roche, Merck, Bayer, Biogen Idec, Gensci, Huaxin, Triprime, Sinovac and Zhaoke, etc. In terms of revenue, the global 3 largest players have a % market share of Recombinant Cytokines Drug in 2021.
This report focuses on Recombinant Cytokines Drug volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Recombinant Cytokines Drug market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Recombinant Cytokines Drug Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Interferon
Recombinant Human Granulocyte Colony-Stimulating
Erythropoietin (EPO)
Recombinant Human Thrombopoietin
Others
Segment by Application
Hepatitis B
Hepatitis C
Multiple Sclerosis
Tumor Therapy
Wound Healing
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Roche
Merck
Bayer
Biogen Idec
Gensci
Huaxin
Triprime
Sinovac
Zhaoke
Kawin
Abcam plc
R&D Systems
Thermo Fisher Scientific
BioLegend
Invitrogen
OriGene
Biorbyt
Qilu Pharmaceutical
Shijiazhuang Pharmaceutical
Amgen
Johnson & Johnson
Kyowa Hakko Kirin
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Recombinant Cytokines Drug Market Overview
1.1 Product Overview and Scope of Recombinant Cytokines Drug
1.2 Recombinant Cytokines Drug Segment by Type
1.2.1 Global Recombinant Cytokines Drug Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Interferon
1.2.3 Recombinant Human Granulocyte Colony-Stimulating
1.2.4 Erythropoietin (EPO)
1.2.5 Recombinant Human Thrombopoietin
1.2.6 Others
1.3 Recombinant Cytokines Drug Segment by Application
1.3.1 Global Recombinant Cytokines Drug Sales Comparison by Application: (2022-2028)
1.3.2 Hepatitis B
1.3.3 Hepatitis C
1.3.4 Multiple Sclerosis
1.3.5 Tumor Therapy
1.3.6 Wound Healing
1.3.7 Others
1.4 Global Recombinant Cytokines Drug Market Size Estimates and Forecasts
1.4.1 Global Recombinant Cytokines Drug Revenue 2017-2028
1.4.2 Global Recombinant Cytokines Drug Sales 2017-2028
1.4.3 Recombinant Cytokines Drug Market Size by Region: 2017 Versus 2021 Versus 2028
2 Recombinant Cytokines Drug Market Competition by Manufacturers
2.1 Global Recombinant Cytokines Drug Sales Market Share by Manufacturers (2017-2022)
2.2 Global Recombinant Cytokines Drug Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Recombinant Cytokines Drug Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Recombinant Cytokines Drug Manufacturing Sites, Area Served, Product Type
2.5 Recombinant Cytokines Drug Market Competitive Situation and Trends
2.5.1 Recombinant Cytokines Drug Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Recombinant Cytokines Drug Players Market Share by Revenue
2.5.3 Global Recombinant Cytokines Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Recombinant Cytokines Drug Retrospective Market Scenario by Region
3.1 Global Recombinant Cytokines Drug Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Recombinant Cytokines Drug Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Recombinant Cytokines Drug Market Facts & Figures by Country
3.3.1 North America Recombinant Cytokines Drug Sales by Country
3.3.2 North America Recombinant Cytokines Drug Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Recombinant Cytokines Drug Market Facts & Figures by Country
3.4.1 Europe Recombinant Cytokines Drug Sales by Country
3.4.2 Europe Recombinant Cytokines Drug Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Recombinant Cytokines Drug Market Facts & Figures by Region
3.5.1 Asia Pacific Recombinant Cytokines Drug Sales by Region
3.5.2 Asia Pacific Recombinant Cytokines Drug Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Recombinant Cytokines Drug Market Facts & Figures by Country
3.6.1 Latin America Recombinant Cytokines Drug Sales by Country
3.6.2 Latin America Recombinant Cytokines Drug Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Recombinant Cytokines Drug Market Facts & Figures by Country
3.7.1 Middle East and Africa Recombinant Cytokines Drug Sales by Country
3.7.2 Middle East and Africa Recombinant Cytokines Drug Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Recombinant Cytokines Drug Historic Market Analysis by Type
4.1 Global Recombinant Cytokines Drug Sales Market Share by Type (2017-2022)
4.2 Global Recombinant Cytokines Drug Revenue Market Share by Type (2017-2022)
4.3 Global Recombinant Cytokines Drug Price by Type (2017-2022)
5 Global Recombinant Cytokines Drug Historic Market Analysis by Application
5.1 Global Recombinant Cytokines Drug Sales Market Share by Application (2017-2022)
5.2 Global Recombinant Cytokines Drug Revenue Market Share by Application (2017-2022)
5.3 Global Recombinant Cytokines Drug Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Corporation Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Recombinant Cytokines Drug Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Roche Recombinant Cytokines Drug Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 Merck
6.2.1 Merck Corporation Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Recombinant Cytokines Drug Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Merck Recombinant Cytokines Drug Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 Bayer
6.3.1 Bayer Corporation Information
6.3.2 Bayer Description and Business Overview
6.3.3 Bayer Recombinant Cytokines Drug Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Bayer Recombinant Cytokines Drug Product Portfolio
6.3.5 Bayer Recent Developments/Updates
6.4 Biogen Idec
6.4.1 Biogen Idec Corporation Information
6.4.2 Biogen Idec Description and Business Overview
6.4.3 Biogen Idec Recombinant Cytokines Drug Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Biogen Idec Recombinant Cytokines Drug Product Portfolio
6.4.5 Biogen Idec Recent Developments/Updates
6.5 Gensci
6.5.1 Gensci Corporation Information
6.5.2 Gensci Description and Business Overview
6.5.3 Gensci Recombinant Cytokines Drug Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Gensci Recombinant Cytokines Drug Product Portfolio
6.5.5 Gensci Recent Developments/Updates
6.6 Huaxin
6.6.1 Huaxin Corporation Information
6.6.2 Huaxin Description and Business Overview
6.6.3 Huaxin Recombinant Cytokines Drug Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Huaxin Recombinant Cytokines Drug Product Portfolio
6.6.5 Huaxin Recent Developments/Updates
6.7 Triprime
6.6.1 Triprime Corporation Information
6.6.2 Triprime Description and Business Overview
6.6.3 Triprime Recombinant Cytokines Drug Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Triprime Recombinant Cytokines Drug Product Portfolio
6.7.5 Triprime Recent Developments/Updates
6.8 Sinovac
6.8.1 Sinovac Corporation Information
6.8.2 Sinovac Description and Business Overview
6.8.3 Sinovac Recombinant Cytokines Drug Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Sinovac Recombinant Cytokines Drug Product Portfolio
6.8.5 Sinovac Recent Developments/Updates
6.9 Zhaoke
6.9.1 Zhaoke Corporation Information
6.9.2 Zhaoke Description and Business Overview
6.9.3 Zhaoke Recombinant Cytokines Drug Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Zhaoke Recombinant Cytokines Drug Product Portfolio
6.9.5 Zhaoke Recent Developments/Updates
6.10 Kawin
6.10.1 Kawin Corporation Information
6.10.2 Kawin Description and Business Overview
6.10.3 Kawin Recombinant Cytokines Drug Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Kawin Recombinant Cytokines Drug Product Portfolio
6.10.5 Kawin Recent Developments/Updates
6.11 Abcam plc
6.11.1 Abcam plc Corporation Information
6.11.2 Abcam plc Recombinant Cytokines Drug Description and Business Overview
6.11.3 Abcam plc Recombinant Cytokines Drug Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Abcam plc Recombinant Cytokines Drug Product Portfolio
6.11.5 Abcam plc Recent Developments/Updates
6.12 R&D Systems
6.12.1 R&D Systems Corporation Information
6.12.2 R&D Systems Recombinant Cytokines Drug Description and Business Overview
6.12.3 R&D Systems Recombinant Cytokines Drug Sales, Revenue and Gross Margin (2017-2022)
6.12.4 R&D Systems Recombinant Cytokines Drug Product Portfolio
6.12.5 R&D Systems Recent Developments/Updates
6.13 Thermo Fisher Scientific
6.13.1 Thermo Fisher Scientific Corporation Information
6.13.2 Thermo Fisher Scientific Recombinant Cytokines Drug Description and Business Overview
6.13.3 Thermo Fisher Scientific Recombinant Cytokines Drug Sales, Revenue and Gross Margin (2017-2022)
6.13.4 Thermo Fisher Scientific Recombinant Cytokines Drug Product Portfolio
6.13.5 Thermo Fisher Scientific Recent Developments/Updates
6.14 BioLegend
6.14.1 BioLegend Corporation Information
6.14.2 BioLegend Recombinant Cytokines Drug Description and Business Overview
6.14.3 BioLegend Recombinant Cytokines Drug Sales, Revenue and Gross Margin (2017-2022)
6.14.4 BioLegend Recombinant Cytokines Drug Product Portfolio
6.14.5 BioLegend Recent Developments/Updates
6.15 Invitrogen
6.15.1 Invitrogen Corporation Information
6.15.2 Invitrogen Recombinant Cytokines Drug Description and Business Overview
6.15.3 Invitrogen Recombinant Cytokines Drug Sales, Revenue and Gross Margin (2017-2022)
6.15.4 Invitrogen Recombinant Cytokines Drug Product Portfolio
6.15.5 Invitrogen Recent Developments/Updates
6.16 OriGene
6.16.1 OriGene Corporation Information
6.16.2 OriGene Recombinant Cytokines Drug Description and Business Overview
6.16.3 OriGene Recombinant Cytokines Drug Sales, Revenue and Gross Margin (2017-2022)
6.16.4 OriGene Recombinant Cytokines Drug Product Portfolio
6.16.5 OriGene Recent Developments/Updates
6.17 Biorbyt
6.17.1 Biorbyt Corporation Information
6.17.2 Biorbyt Recombinant Cytokines Drug Description and Business Overview
6.17.3 Biorbyt Recombinant Cytokines Drug Sales, Revenue and Gross Margin (2017-2022)
6.17.4 Biorbyt Recombinant Cytokines Drug Product Portfolio
6.17.5 Biorbyt Recent Developments/Updates
6.18 Qilu Pharmaceutical
6.18.1 Qilu Pharmaceutical Corporation Information
6.18.2 Qilu Pharmaceutical Recombinant Cytokines Drug Description and Business Overview
6.18.3 Qilu Pharmaceutical Recombinant Cytokines Drug Sales, Revenue and Gross Margin (2017-2022)
6.18.4 Qilu Pharmaceutical Recombinant Cytokines Drug Product Portfolio
6.18.5 Qilu Pharmaceutical Recent Developments/Updates
6.19 Shijiazhuang Pharmaceutical
6.19.1 Shijiazhuang Pharmaceutical Corporation Information
6.19.2 Shijiazhuang Pharmaceutical Recombinant Cytokines Drug Description and Business Overview
6.19.3 Shijiazhuang Pharmaceutical Recombinant Cytokines Drug Sales, Revenue and Gross Margin (2017-2022)
6.19.4 Shijiazhuang Pharmaceutical Recombinant Cytokines Drug Product Portfolio
6.19.5 Shijiazhuang Pharmaceutical Recent Developments/Updates
6.20 Amgen
6.20.1 Amgen Corporation Information
6.20.2 Amgen Recombinant Cytokines Drug Description and Business Overview
6.20.3 Amgen Recombinant Cytokines Drug Sales, Revenue and Gross Margin (2017-2022)
6.20.4 Amgen Recombinant Cytokines Drug Product Portfolio
6.20.5 Amgen Recent Developments/Updates
6.21 Johnson & Johnson
6.21.1 Johnson & Johnson Corporation Information
6.21.2 Johnson & Johnson Recombinant Cytokines Drug Description and Business Overview
6.21.3 Johnson & Johnson Recombinant Cytokines Drug Sales, Revenue and Gross Margin (2017-2022)
6.21.4 Johnson & Johnson Recombinant Cytokines Drug Product Portfolio
6.21.5 Johnson & Johnson Recent Developments/Updates
6.22 Kyowa Hakko Kirin
6.22.1 Kyowa Hakko Kirin Corporation Information
6.22.2 Kyowa Hakko Kirin Recombinant Cytokines Drug Description and Business Overview
6.22.3 Kyowa Hakko Kirin Recombinant Cytokines Drug Sales, Revenue and Gross Margin (2017-2022)
6.22.4 Kyowa Hakko Kirin Recombinant Cytokines Drug Product Portfolio
6.22.5 Kyowa Hakko Kirin Recent Developments/Updates
7 Recombinant Cytokines Drug Manufacturing Cost Analysis
7.1 Recombinant Cytokines Drug Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Recombinant Cytokines Drug
7.4 Recombinant Cytokines Drug Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Recombinant Cytokines Drug Distributors List
8.3 Recombinant Cytokines Drug Customers
9 Recombinant Cytokines Drug Market Dynamics
9.1 Recombinant Cytokines Drug Industry Trends
9.2 Recombinant Cytokines Drug Market Drivers
9.3 Recombinant Cytokines Drug Market Challenges
9.4 Recombinant Cytokines Drug Market Restraints
10 Global Market Forecast
10.1 Recombinant Cytokines Drug Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Recombinant Cytokines Drug by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Recombinant Cytokines Drug by Type (2023-2028)
10.2 Recombinant Cytokines Drug Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Recombinant Cytokines Drug by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Recombinant Cytokines Drug by Application (2023-2028)
10.3 Recombinant Cytokines Drug Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Recombinant Cytokines Drug by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Recombinant Cytokines Drug by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Recombinant Cytokines Drug Sales Growth Rate Comparison by Type (2022-2028) & (KG) & (US$ Million)
Table 2. Global Recombinant Cytokines Drug Sales Growth Rate Comparison by Application (2022-2028) & (KG) & (US$ Million)
Table 3. Global Recombinant Cytokines Drug Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Recombinant Cytokines Drug Market Competitive Situation by Manufacturers in 2021
Table 5. Global Recombinant Cytokines Drug Sales (KG) of Key Manufacturers (2017-2022)
Table 6. Global Recombinant Cytokines Drug Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Recombinant Cytokines Drug Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Recombinant Cytokines Drug Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Recombinant Cytokines Drug Average Price (USD/g) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Recombinant Cytokines Drug Manufacturing Sites and Area Served
Table 11. Manufacturers Recombinant Cytokines Drug Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Recombinant Cytokines Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant Cytokines Drug as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Recombinant Cytokines Drug Sales by Region (2017-2022) & (KG)
Table 16. Global Recombinant Cytokines Drug Sales Market Share by Region (2017-2022)
Table 17. Global Recombinant Cytokines Drug Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Recombinant Cytokines Drug Revenue Market Share by Region (2017-2022)
Table 19. North America Recombinant Cytokines Drug Sales by Country (2017-2022) & (KG)
Table 20. North America Recombinant Cytokines Drug Sales Market Share by Country (2017-2022)
Table 21. North America Recombinant Cytokines Drug Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Recombinant Cytokines Drug Revenue Market Share by Country (2017-2022)
Table 23. Europe Recombinant Cytokines Drug Sales by Country (2017-2022) & (KG)
Table 24. Europe Recombinant Cytokines Drug Sales Market Share by Country (2017-2022)
Table 25. Europe Recombinant Cytokines Drug Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Recombinant Cytokines Drug Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Recombinant Cytokines Drug Sales by Region (2017-2022) & (KG)
Table 28. Asia Pacific Recombinant Cytokines Drug Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Recombinant Cytokines Drug Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Recombinant Cytokines Drug Revenue Market Share by Region (2017-2022)
Table 31. Latin America Recombinant Cytokines Drug Sales by Country (2017-2022) & (KG)
Table 32. Latin America Recombinant Cytokines Drug Sales Market Share by Country (2017-2022)
Table 33. Latin America Recombinant Cytokines Drug Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Recombinant Cytokines Drug Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Recombinant Cytokines Drug Sales by Country (2017-2022) & (KG)
Table 36. Middle East and Africa Recombinant Cytokines Drug Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Recombinant Cytokines Drug Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Recombinant Cytokines Drug Revenue Market Share by Country (2017-2022)
Table 39. Global Recombinant Cytokines Drug Sales by Type (2017-2022) & (KG)
Table 40. Global Recombinant Cytokines Drug Sales Market Share by Type (2017-2022)
Table 41. Global Recombinant Cytokines Drug Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Recombinant Cytokines Drug Revenue Share by Type (2017-2022)
Table 43. Global Recombinant Cytokines Drug Price by Type (2017-2022) & (USD/g)
Table 44. Global Recombinant Cytokines Drug Sales (KG) by Application (2017-2022)
Table 45. Global Recombinant Cytokines Drug Sales Market Share by Application (2017-2022)
Table 46. Global Recombinant Cytokines Drug Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Recombinant Cytokines Drug Revenue Share by Application (2017-2022)
Table 48. Global Recombinant Cytokines Drug Price by Application (2017-2022) & (USD/g)
Table 49. Roche Corporation Information
Table 50. Roche Description and Business Overview
Table 51. Roche Recombinant Cytokines Drug Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
Table 52. Roche Recombinant Cytokines Drug Product
Table 53. Roche Recent Developments/Updates
Table 54. Merck Corporation Information
Table 55. Merck Description and Business Overview
Table 56. Merck Recombinant Cytokines Drug Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
Table 57. Merck Recombinant Cytokines Drug Product
Table 58. Merck Recent Developments/Updates
Table 59. Bayer Corporation Information
Table 60. Bayer Description and Business Overview
Table 61. Bayer Recombinant Cytokines Drug Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
Table 62. Bayer Recombinant Cytokines Drug Product
Table 63. Bayer Recent Developments/Updates
Table 64. Biogen Idec Corporation Information
Table 65. Biogen Idec Description and Business Overview
Table 66. Biogen Idec Recombinant Cytokines Drug Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
Table 67. Biogen Idec Recombinant Cytokines Drug Product
Table 68. Biogen Idec Recent Developments/Updates
Table 69. Gensci Corporation Information
Table 70. Gensci Description and Business Overview
Table 71. Gensci Recombinant Cytokines Drug Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
Table 72. Gensci Recombinant Cytokines Drug Product
Table 73. Gensci Recent Developments/Updates
Table 74. Huaxin Corporation Information
Table 75. Huaxin Description and Business Overview
Table 76. Huaxin Recombinant Cytokines Drug Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
Table 77. Huaxin Recombinant Cytokines Drug Product
Table 78. Huaxin Recent Developments/Updates
Table 79. Triprime Corporation Information
Table 80. Triprime Description and Business Overview
Table 81. Triprime Recombinant Cytokines Drug Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
Table 82. Triprime Recombinant Cytokines Drug Product
Table 83. Triprime Recent Developments/Updates
Table 84. Sinovac Corporation Information
Table 85. Sinovac Description and Business Overview
Table 86. Sinovac Recombinant Cytokines Drug Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
Table 87. Sinovac Recombinant Cytokines Drug Product
Table 88. Sinovac Recent Developments/Updates
Table 89. Zhaoke Corporation Information
Table 90. Zhaoke Description and Business Overview
Table 91. Zhaoke Recombinant Cytokines Drug Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
Table 92. Zhaoke Recombinant Cytokines Drug Product
Table 93. Zhaoke Recent Developments/Updates
Table 94. Kawin Corporation Information
Table 95. Kawin Description and Business Overview
Table 96. Kawin Recombinant Cytokines Drug Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
Table 97. Kawin Recombinant Cytokines Drug Product
Table 98. Kawin Recent Developments/Updates
Table 99. Abcam plc Corporation Information
Table 100. Abcam plc Description and Business Overview
Table 101. Abcam plc Recombinant Cytokines Drug Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
Table 102. Abcam plc Recombinant Cytokines Drug Product
Table 103. Abcam plc Recent Developments/Updates
Table 104. R&D Systems Corporation Information
Table 105. R&D Systems Description and Business Overview
Table 106. R&D Systems Recombinant Cytokines Drug Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
Table 107. R&D Systems Recombinant Cytokines Drug Product
Table 108. R&D Systems Recent Developments/Updates
Table 109. Thermo Fisher Scientific Corporation Information
Table 110. Thermo Fisher Scientific Description and Business Overview
Table 111. Thermo Fisher Scientific Recombinant Cytokines Drug Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
Table 112. Thermo Fisher Scientific Recombinant Cytokines Drug Product
Table 113. Thermo Fisher Scientific Recent Developments/Updates
Table 114. BioLegend Corporation Information
Table 115. BioLegend Description and Business Overview
Table 116. BioLegend Recombinant Cytokines Drug Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
Table 117. BioLegend Recombinant Cytokines Drug Product
Table 118. BioLegend Recent Developments/Updates
Table 119. Invitrogen Corporation Information
Table 120. Invitrogen Description and Business Overview
Table 121. Invitrogen Recombinant Cytokines Drug Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
Table 122. Invitrogen Recombinant Cytokines Drug Product
Table 123. Invitrogen Recent Developments/Updates
Table 124. OriGene Corporation Information
Table 125. OriGene Description and Business Overview
Table 126. OriGene Recombinant Cytokines Drug Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
Table 127. OriGene Recombinant Cytokines Drug Product
Table 128. OriGene Recent Developments/Updates
Table 129. Biorbyt Corporation Information
Table 130. Biorbyt Description and Business Overview
Table 131. Biorbyt Recombinant Cytokines Drug Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
Table 132. Biorbyt Recombinant Cytokines Drug Product
Table 133. Biorbyt Recent Developments/Updates
Table 134. Qilu Pharmaceutical Corporation Information
Table 135. Qilu Pharmaceutical Description and Business Overview
Table 136. Qilu Pharmaceutical Recombinant Cytokines Drug Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
Table 137. Qilu Pharmaceutical Recombinant Cytokines Drug Product
Table 138. Qilu Pharmaceutical Recent Developments/Updates
Table 139. Shijiazhuang Pharmaceutical Corporation Information
Table 140. Shijiazhuang Pharmaceutical Description and Business Overview
Table 141. Shijiazhuang Pharmaceutical Recombinant Cytokines Drug Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
Table 142. Shijiazhuang Pharmaceutical Recombinant Cytokines Drug Product
Table 143. Shijiazhuang Pharmaceutical Recent Developments/Updates
Table 144. Amgen Corporation Information
Table 145. Amgen Description and Business Overview
Table 146. Amgen Recombinant Cytokines Drug Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
Table 147. Amgen Recombinant Cytokines Drug Product
Table 148. Amgen Recent Developments/Updates
Table 149. Johnson & Johnson Corporation Information
Table 150. Johnson & Johnson Description and Business Overview
Table 151. Johnson & Johnson Recombinant Cytokines Drug Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
Table 152. Johnson & Johnson Recombinant Cytokines Drug Product
Table 153. Johnson & Johnson Recent Developments/Updates
Table 154. Kyowa Hakko Kirin Corporation Information
Table 155. Kyowa Hakko Kirin Description and Business Overview
Table 156. Kyowa Hakko Kirin Recombinant Cytokines Drug Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
Table 157. Kyowa Hakko Kirin Recombinant Cytokines Drug Product
Table 158. Kyowa Hakko Kirin Recent Developments/Updates
Table 159. Production Base and Market Concentration Rate of Raw Material
Table 160. Key Suppliers of Raw Materials
Table 161. Recombinant Cytokines Drug Distributors List
Table 162. Recombinant Cytokines Drug Customers List
Table 163. Recombinant Cytokines Drug Market Trends
Table 164. Recombinant Cytokines Drug Market Drivers
Table 165. Recombinant Cytokines Drug Market Challenges
Table 166. Recombinant Cytokines Drug Market Restraints
Table 167. Global Recombinant Cytokines Drug Sales Forecast by Type (2023-2028) & (KG)
Table 168. Global Recombinant Cytokines Drug Sales Market Share Forecast by Type (2023-2028)
Table 169. Global Recombinant Cytokines Drug Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 170. Global Recombinant Cytokines Drug Revenue Market Share Forecast by Type (2023-2028)
Table 171. Global Recombinant Cytokines Drug Sales Forecast by Application (2023-2028) & (KG)
Table 172. Global Recombinant Cytokines Drug Sales Market Share Forecast by Application (2023-2028)
Table 173. Global Recombinant Cytokines Drug Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 174. Global Recombinant Cytokines Drug Revenue Market Share Forecast by Application (2023-2028)
Table 175. Global Recombinant Cytokines Drug Sales Forecast by Region (2023-2028) & (KG)
Table 176. Global Recombinant Cytokines Drug Sales Market Share Forecast by Region (2023-2028)
Table 177. Global Recombinant Cytokines Drug Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 178. Global Recombinant Cytokines Drug Revenue Market Share Forecast by Region (2023-2028)
Table 179. Research Programs/Design for This Report
Table 180. Key Data Information from Secondary Sources
Table 181. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Recombinant Cytokines Drug
Figure 2. Global Recombinant Cytokines Drug Market Share by Type in 2021 & 2028
Figure 3. Interferon Product Picture
Figure 4. Recombinant Human Granulocyte Colony-Stimulating Product Picture
Figure 5. Erythropoietin (EPO) Product Picture
Figure 6. Recombinant Human Thrombopoietin Product Picture
Figure 7. Others Product Picture
Figure 8. Global Recombinant Cytokines Drug Market Share by Application in 2021 & 2028
Figure 9. Hepatitis B
Figure 10. Hepatitis C
Figure 11. Multiple Sclerosis
Figure 12. Tumor Therapy
Figure 13. Wound Healing
Figure 14. Others
Figure 15. Global Recombinant Cytokines Drug Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 16. Global Recombinant Cytokines Drug Market Size (2017-2028) & (US$ Million)
Figure 17. Global Recombinant Cytokines Drug Sales (2017-2028) & (KG)
Figure 18. Recombinant Cytokines Drug Sales Share by Manufacturers in 2021
Figure 19. Global Recombinant Cytokines Drug Revenue Share by Manufacturers in 2021
Figure 20. The Global 5 and 10 Largest Recombinant Cytokines Drug Players: Market Share by Revenue in 2021
Figure 21. Recombinant Cytokines Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 22. Global Recombinant Cytokines Drug Sales Market Share by Region (2017-2022)
Figure 23. Global Recombinant Cytokines Drug Sales Market Share by Region in 2021
Figure 24. Global Recombinant Cytokines Drug Revenue Market Share by Region (2017-2022)
Figure 25. Global Recombinant Cytokines Drug Revenue Market Share by Region in 2021
Figure 26. U.S. Recombinant Cytokines Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. Canada Recombinant Cytokines Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. Germany Recombinant Cytokines Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. France Recombinant Cytokines Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. U.K. Recombinant Cytokines Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. Italy Recombinant Cytokines Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. Russia Recombinant Cytokines Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. China Recombinant Cytokines Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Japan Recombinant Cytokines Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. South Korea Recombinant Cytokines Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. India Recombinant Cytokines Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Australia Recombinant Cytokines Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Taiwan Recombinant Cytokines Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Indonesia Recombinant Cytokines Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Thailand Recombinant Cytokines Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Malaysia Recombinant Cytokines Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Philippines Recombinant Cytokines Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Vietnam Recombinant Cytokines Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. Mexico Recombinant Cytokines Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 45. Brazil Recombinant Cytokines Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 46. Argentina Recombinant Cytokines Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 47. Turkey Recombinant Cytokines Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 48. Saudi Arabia Recombinant Cytokines Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 49. U.A.E Recombinant Cytokines Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 50. Sales Market Share of Recombinant Cytokines Drug by Type (2017-2022)
Figure 51. Manufacturing Cost Structure of Recombinant Cytokines Drug
Figure 52. Manufacturing Process Analysis of Recombinant Cytokines Drug
Figure 53. Recombinant Cytokines Drug Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
